Among them, high iodine intake is a high-risk factor for BRAF gene mutations in PTC patients; RET gene testing can be performed for MTC patients, and RET mutations are closely related to tumor invasiveness and poor prognosis (19). The gene discussed is RET; the disease is neoplasm.